hormonal contraceptive

From Aaushi
Jump to navigation Jump to search
[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]

Indications

Contraindications

Adverse effects

* progestin-only contraceptives an option?[11]

Drug interactions

Notes

More general terms

More specific terms

References

  1. ↑ 1.0 1.1 1.2 Journal Watch 22(3):21-22, 2002 Tanis BC et al Oral contraceptives and the risk of myocardial infarction. N Engl J Med 345:1787, 2001 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11752354
  2. ↑ 2.0 2.1 Journal Watch 22(9):74, 2002 Munoz N et al Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11943256
    Moreno V et al Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 359:1085, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11943255
  3. ↑ 3.0 3.1 Journal Watch 22(15):120-21, 2002 MarchBanks PA et al Oral contraceptives and the risk of breast cancer. N Engl J Med 346:2025, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12087137
    Davidson NE & Helzlsouer KJ Good news about oral contraceptives. N Engl J Med 346:2078, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12087145
  4. ↑ 4.0 4.1 Prescriber's Letter 11(2):8 2004 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=200203&pb=PRL (subscription needed) http://www.prescribersletter.com
  5. ↑ 5.0 5.1 Prescriber's Letter 12(9): 2005 Ortho Evra and the Risk of Thromboembolism Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210902&pb=PRL (subscription needed) http://www.prescribersletter.com
  6. ↑ 6.0 6.1 Townsend MK et al Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol 2009 May; 181:2170. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19296979
    Jackson SL and Fihn SD Exogenous estrogen and urinary incontinence. J Urol 2009 May; 181:1989. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19286197
  7. ↑ 7.0 7.1 Stringer EM et al HIV disease progression by hormonal contraceptive method: Secondary analysis of a randomized trial. AIDS 2009 Jul 17; 23:1377. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19448528
  8. ↑ 8.0 8.1 Hannaford PC et al. Mortality among contraceptive pill users: Cohort evidence from Royal College of General Practitioners' Oral Contraception Study. BMJ 2010 Mar 11; 340:c927. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/20223876 <Internet> http://dx.doi.org/10.1136/bmj.c927
  9. ↑ 9.0 9.1 Jick SS and Hernandez RK Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case- control study using United States claims data BMJ 2011; 342:d2151 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21511805 <Internet> http://www.bmj.com/content/342/bmj.d2151
    Parkin L et al Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database BMJ 2011; 342:d2139 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21511804 <Internet> http://www.bmj.com/content/342/bmj.d2139
    Dunn N The risk of deep venous thrombosis with oral contraceptives containing drospirenone BMJ 2011; 342:d2519 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21511807 <Internet> http://www.bmj.com/content/342/bmj.d2519.extract
    FDA Safety Alert: Posted 05/31/2011 Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm257337.htm
  10. ↑ 10.0 10.1 Lidegaard O et al Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 BMJ 2011; 343:d6423 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22027398 <Internet> http://www.bmj.com/content/343/bmj.d6423.full
    Hannaford PC The progestogen content of combined oral contraceptives and venous thromboembolic risk BMJ 2011; 343:d6592 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22028481 <Internet> http://www.bmj.com/content/343/bmj.d6592.extract
  11. ↑ 11.0 11.1 11.2 11.3 Lidegaard O et al Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception N Engl J Med 2012; 366:2257-2266June 14, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22693997 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1111840
    Petitti DB Hormonal Contraceptives and Arterial Thrombosis - Not Risk-free but Safe Enough N Engl J Med 2012; 366:2316-2318June 14, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22694003 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1204769
  12. ↑ 12.0 12.1 12.2 Andersen L et al Hormonal contraceptive use and risk of glioma among younger women a nationwide case-control study. British Journal of Clinical Pharmacology. Jan 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25345919 <Internet> http://onlinelibrary.wiley.com/doi/10.1111/bcp.12535/abstract
  13. ↑ 13.0 13.1 Harmon QE, Umbach DH, Baird DD Use of Estrogen-Containing Contraception Is Associated With Increased Concentrations of 25-Hydroxy Vitamin D. J Clin Endocrinol Metab 101: Aug, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27490916 <Internet> http://press.endocrine.org/doi/pdf/10.1210/jc.2016-1658
  14. ↑ 14.0 14.1 Iversen L, Fielding S, Lidegaard O et al Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 2018;362:k3609 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30257920 Free full text https://www.bmj.com/content/362/bmj.k3609
  15. ↑ 15.0 15.1 15.2 15.3 Medical Knowledge Self Assessment Program (MKSAP) 19 American College of Physicians, Philadelphia 2022
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
Retrieved from "https://aaushi.info/w/index.php?title=A32961&oldid=1199923"